- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
According to our latest study, the global Natural Killer Cell Therapy market size was valued at USD 263.2 million in 2022 and is forecast to a readjusted size of USD 1131.3 million by 2029 with a CAGR of 23.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
This report is a detailed and comprehensive analysis for global Natural Killer Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Natural Killer Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Natural Killer Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Natural Killer Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Natural Killer Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Natural Killer Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Natural Killer Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences and Glycostem Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Natural Killer Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Market segment by Application
Cancer
Gastrointestinal Diseases
Others
Market segment by players, this report covers
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Natural Killer Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Natural Killer Cell Therapy, with revenue, gross margin and global market share of Natural Killer Cell Therapy from 2018 to 2023.
Chapter 3, the Natural Killer Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Natural Killer Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Natural Killer Cell Therapy.
Chapter 13, to describe Natural Killer Cell Therapy research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Natural Killer Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Natural Killer Cell Therapy by Type
1.3.1 Overview: Global Natural Killer Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Natural Killer Cell Therapy Consumption Value Market Share by Type in 2022
1.3.3 NK Cell Therapies
1.3.4 NK Cell Directed Antibodies
1.4 Global Natural Killer Cell Therapy Market by Application
1.4.1 Overview: Global Natural Killer Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer
1.4.3 Gastrointestinal Diseases
1.4.4 Others
1.5 Global Natural Killer Cell Therapy Market Size & Forecast
1.6 Global Natural Killer Cell Therapy Market Size and Forecast by Region
1.6.1 Global Natural Killer Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Natural Killer Cell Therapy Market Size by Region, (2018-2029)
1.6.3 North America Natural Killer Cell Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Natural Killer Cell Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Natural Killer Cell Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Natural Killer Cell Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Natural Killer Cell Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Nektar Therapeutics
2.1.1 Nektar Therapeutics Details
2.1.2 Nektar Therapeutics Major Business
2.1.3 Nektar Therapeutics Natural Killer Cell Therapy Product and Solutions
2.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Nektar Therapeutics Recent Developments and Future Plans
2.2 Innate Pharma SA
2.2.1 Innate Pharma SA Details
2.2.2 Innate Pharma SA Major Business
2.2.3 Innate Pharma SA Natural Killer Cell Therapy Product and Solutions
2.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Innate Pharma SA Recent Developments and Future Plans
2.3 Affimed
2.3.1 Affimed Details
2.3.2 Affimed Major Business
2.3.3 Affimed Natural Killer Cell Therapy Product and Solutions
2.3.4 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Affimed Recent Developments and Future Plans
2.4 Chipscreen Biosciences
2.4.1 Chipscreen Biosciences Details
2.4.2 Chipscreen Biosciences Major Business
2.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Product and Solutions
2.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Chipscreen Biosciences Recent Developments and Future Plans
2.5 Glycostem Therapeutics
2.5.1 Glycostem Therapeutics Details
2.5.2 Glycostem Therapeutics Major Business
2.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Product and Solutions
2.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Glycostem Therapeutics Recent Developments and Future Plans
2.6 Fate Therapeutics
2.6.1 Fate Therapeutics Details
2.6.2 Fate Therapeutics Major Business
2.6.3 Fate Therapeutics Natural Killer Cell Therapy Product and Solutions
2.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Fate Therapeutics Recent Developments and Future Plans
2.7 Dragonfly Therapeutics
2.7.1 Dragonfly Therapeutics Details
2.7.2 Dragonfly Therapeutics Major Business
2.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Product and Solutions
2.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Dragonfly Therapeutics Recent Developments and Future Plans
2.8 Kiadis Pharma
2.8.1 Kiadis Pharma Details
2.8.2 Kiadis Pharma Major Business
2.8.3 Kiadis Pharma Natural Killer Cell Therapy Product and Solutions
2.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Kiadis Pharma Recent Developments and Future Plans
2.9 Nkarta Therapeutics
2.9.1 Nkarta Therapeutics Details
2.9.2 Nkarta Therapeutics Major Business
2.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Product and Solutions
2.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nkarta Therapeutics Recent Developments and Future Plans
2.10 NantKwest
2.10.1 NantKwest Details
2.10.2 NantKwest Major Business
2.10.3 NantKwest Natural Killer Cell Therapy Product and Solutions
2.10.4 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 NantKwest Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Natural Killer Cell Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Natural Killer Cell Therapy by Company Revenue
3.2.2 Top 3 Natural Killer Cell Therapy Players Market Share in 2022
3.2.3 Top 6 Natural Killer Cell Therapy Players Market Share in 2022
3.3 Natural Killer Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Natural Killer Cell Therapy Market: Region Footprint
3.3.2 Natural Killer Cell Therapy Market: Company Product Type Footprint
3.3.3 Natural Killer Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Natural Killer Cell Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Natural Killer Cell Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Natural Killer Cell Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Natural Killer Cell Therapy Market Forecast by Application (2024-2029)
6 North America
6.1 North America Natural Killer Cell Therapy Consumption Value by Type (2018-2029)
6.2 North America Natural Killer Cell Therapy Consumption Value by Application (2018-2029)
6.3 North America Natural Killer Cell Therapy Market Size by Country
6.3.1 North America Natural Killer Cell Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Natural Killer Cell Therapy Consumption Value by Type (2018-2029)
7.2 Europe Natural Killer Cell Therapy Consumption Value by Application (2018-2029)
7.3 Europe Natural Killer Cell Therapy Market Size by Country
7.3.1 Europe Natural Killer Cell Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
7.3.3 France Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cell Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Natural Killer Cell Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Natural Killer Cell Therapy Consumption Value by Region (2018-2029)
8.3.2 China Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
8.3.5 India Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
9 South America
9.1 South America Natural Killer Cell Therapy Consumption Value by Type (2018-2029)
9.2 South America Natural Killer Cell Therapy Consumption Value by Application (2018-2029)
9.3 South America Natural Killer Cell Therapy Market Size by Country
9.3.1 South America Natural Killer Cell Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cell Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Natural Killer Cell Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Natural Killer Cell Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Natural Killer Cell Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Natural Killer Cell Therapy Market Drivers
11.2 Natural Killer Cell Therapy Market Restraints
11.3 Natural Killer Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Natural Killer Cell Therapy Industry Chain
12.2 Natural Killer Cell Therapy Upstream Analysis
12.3 Natural Killer Cell Therapy Midstream Analysis
12.4 Natural Killer Cell Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Natural Killer Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Natural Killer Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Natural Killer Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Natural Killer Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Nektar Therapeutics Company Information, Head Office, and Major Competitors
Table 6. Nektar Therapeutics Major Business
Table 7. Nektar Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 8. Nektar Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Nektar Therapeutics Recent Developments and Future Plans
Table 10. Innate Pharma SA Company Information, Head Office, and Major Competitors
Table 11. Innate Pharma SA Major Business
Table 12. Innate Pharma SA Natural Killer Cell Therapy Product and Solutions
Table 13. Innate Pharma SA Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Innate Pharma SA Recent Developments and Future Plans
Table 15. Affimed Company Information, Head Office, and Major Competitors
Table 16. Affimed Major Business
Table 17. Affimed Natural Killer Cell Therapy Product and Solutions
Table 18. Affimed Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Affimed Recent Developments and Future Plans
Table 20. Chipscreen Biosciences Company Information, Head Office, and Major Competitors
Table 21. Chipscreen Biosciences Major Business
Table 22. Chipscreen Biosciences Natural Killer Cell Therapy Product and Solutions
Table 23. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Chipscreen Biosciences Recent Developments and Future Plans
Table 25. Glycostem Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Glycostem Therapeutics Major Business
Table 27. Glycostem Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 28. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Glycostem Therapeutics Recent Developments and Future Plans
Table 30. Fate Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Fate Therapeutics Major Business
Table 32. Fate Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 33. Fate Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Fate Therapeutics Recent Developments and Future Plans
Table 35. Dragonfly Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Dragonfly Therapeutics Major Business
Table 37. Dragonfly Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 38. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Dragonfly Therapeutics Recent Developments and Future Plans
Table 40. Kiadis Pharma Company Information, Head Office, and Major Competitors
Table 41. Kiadis Pharma Major Business
Table 42. Kiadis Pharma Natural Killer Cell Therapy Product and Solutions
Table 43. Kiadis Pharma Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Kiadis Pharma Recent Developments and Future Plans
Table 45. Nkarta Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Nkarta Therapeutics Major Business
Table 47. Nkarta Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 48. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nkarta Therapeutics Recent Developments and Future Plans
Table 50. NantKwest Company Information, Head Office, and Major Competitors
Table 51. NantKwest Major Business
Table 52. NantKwest Natural Killer Cell Therapy Product and Solutions
Table 53. NantKwest Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. NantKwest Recent Developments and Future Plans
Table 55. Global Natural Killer Cell Therapy Revenue (USD Million) by Players (2018-2023)
Table 56. Global Natural Killer Cell Therapy Revenue Share by Players (2018-2023)
Table 57. Breakdown of Natural Killer Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Natural Killer Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Natural Killer Cell Therapy Players
Table 60. Natural Killer Cell Therapy Market: Company Product Type Footprint
Table 61. Natural Killer Cell Therapy Market: Company Product Application Footprint
Table 62. Natural Killer Cell Therapy New Market Entrants and Barriers to Market Entry
Table 63. Natural Killer Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Natural Killer Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Natural Killer Cell Therapy Consumption Value Share by Type (2018-2023)
Table 66. Global Natural Killer Cell Therapy Consumption Value Forecast by Type (2024-2029)
Table 67. Global Natural Killer Cell Therapy Consumption Value by Application (2018-2023)
Table 68. Global Natural Killer Cell Therapy Consumption Value Forecast by Application (2024-2029)
Table 69. North America Natural Killer Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Natural Killer Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Natural Killer Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Natural Killer Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Natural Killer Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Natural Killer Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Natural Killer Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Natural Killer Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Natural Killer Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Natural Killer Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Natural Killer Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Natural Killer Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Natural Killer Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Natural Killer Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Natural Killer Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Natural Killer Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Natural Killer Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Natural Killer Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Natural Killer Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Natural Killer Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Natural Killer Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Natural Killer Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Natural Killer Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Natural Killer Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Natural Killer Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Natural Killer Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Natural Killer Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Natural Killer Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Natural Killer Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Natural Killer Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Natural Killer Cell Therapy Raw Material
Table 100. Key Suppliers of Natural Killer Cell Therapy Raw Materials
List of Figures
Figure 1. Natural Killer Cell Therapy Picture
Figure 2. Global Natural Killer Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Natural Killer Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. NK Cell Therapies
Figure 5. NK Cell Directed Antibodies
Figure 6. Global Natural Killer Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Natural Killer Cell Therapy Consumption Value Market Share by Application in 2022
Figure 8. Cancer Picture
Figure 9. Gastrointestinal Diseases Picture
Figure 10. Others Picture
Figure 11. Global Natural Killer Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Natural Killer Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Natural Killer Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Natural Killer Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Natural Killer Cell Therapy Consumption Value Market Share by Region in 2022
Figure 16. North America Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Natural Killer Cell Therapy Revenue Share by Players in 2022
Figure 22. Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Natural Killer Cell Therapy Market Share in 2022
Figure 24. Global Top 6 Players Natural Killer Cell Therapy Market Share in 2022
Figure 25. Global Natural Killer Cell Therapy Consumption Value Share by Type (2018-2023)
Figure 26. Global Natural Killer Cell Therapy Market Share Forecast by Type (2024-2029)
Figure 27. Global Natural Killer Cell Therapy Consumption Value Share by Application (2018-2023)
Figure 28. Global Natural Killer Cell Therapy Market Share Forecast by Application (2024-2029)
Figure 29. North America Natural Killer Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Natural Killer Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Natural Killer Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Natural Killer Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Natural Killer Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Natural Killer Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. France Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Natural Killer Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Natural Killer Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Natural Killer Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 46. China Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. India Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Natural Killer Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Natural Killer Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Natural Killer Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Natural Killer Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Natural Killer Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Natural Killer Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Natural Killer Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. Natural Killer Cell Therapy Market Drivers
Figure 64. Natural Killer Cell Therapy Market Restraints
Figure 65. Natural Killer Cell Therapy Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Natural Killer Cell Therapy in 2022
Figure 68. Manufacturing Process Analysis of Natural Killer Cell Therapy
Figure 69. Natural Killer Cell Therapy Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
